Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Ninth European International Kidney Cancer Symposium /
Optimising metastic renal cell carcinoma (mRCC): Treatment lessons from the real world: Introduction

25th - 26th Apr 2014

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 23.09.14
Views: 2240

Dr Thomas Hutson - Baylor University Medical Center, Dallas, USA

Dr Hutson introduces the agenda for the symposium: "Optimising metastatic renal cell carcinoma (mRCC) treatment: Lessons from the real world".

Session objectives include discussing the first-line treatment options for mRCC, assessing criteria for optimising mRCC treatment, exploring how real-world experience can inform options for first-line treatment, and discussing further development in mRCC management.

This symposium has been supported by a grant from GlaxoSmithKline.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation